Pink Sheet Podcast: US FDA Involved In Drug Pricing Deal, DOJ’s Off-Label Promotion Policy

 
• By Derrick Gingery, Sarah Karlin-Smith, and Nielsen Hobbs
  
Pink Sheet podcast
Will the Justice Department upend FDA policy on the scientific exchange of information about off-label use? • Source: Citeline/Shutterstock

More from Podcasts

More from Pink Sheet